Key Themes & Topics
ADC Supply Chain Integration
Solving the "fragmentation fracture" by de-risking the logistics of high-potency payloads (HPAPI) and linkers sourced from Asia for European conjugation.
Next-Gen Conjugation & Bispecifics
Accessing Asian innovation in Bispecific ADCs (bsADCs) and novel linker chemistries, moving from outsourcing to co-development and licensing.
Analytical Harmonisation
Standardising analytical assays (DAR, free payload) to ensure seamless technology transfer and product comparability between EU labs and Asian sites.
Manufacturing Scalability & HPAPI Safety
Best practices for high-potency containment, single-pot synthesis, and scaling up purification for commercial ADC launches.
John Bridgeman | CSO, Immunokey, UK
"Thanks for the invite to speak at the event. It was a really enjoyable meeting and a great opportunity to present our work to the community. Identifying key partners for ImmunoKey’s development plan is a critical aspect of getting our therapies to patients; the CGT and Biologics Manufacturing DACH meeting offered us the opportunity to engage with key CDMOs who can help us achieve this goal."
Terry Gray | Field Marketing Manager, Merck
"I had the pleasure of collaborating with the IMAPAC team during the Irish leg of the Biologics World event in February 2026. The organisers were exceptionally receptive and helpful, ensuring a seamless experience throughout the planning, exhibition logistics, partnering sessions, and sponsor visibility. Their proactive approach in connecting us with potential partners significantly enhanced our ROI. We are already exploring future opportunities to work with the IMAPAC team."
WHO
For Heads of CMC, ADC Development, and Supply Chain Leaders focused on the complex development and manufacturing of antibody-drug conjugates.
WHAT
The technical summit for ADC supply chain integration, connecting linker/payload chemists with antibody manufacturers and fill-finish specialists.
WHY
To overcome the supply chain fragmentation that plagues ADCs, ensuring you have the capacity and technical capability to meet the 2030 market demand.
Senior Attendees
Meet a concentrated audience of Heads of CMC, ADC Development, and Supply Chain Leaders focused on the end-to-end production of antibody-drug conjugates.
Expert Speakers
Hear from world-class leaders in conjugation chemistry, HPAPI containment, analytical characterisation, and supply chain integration for complex biologics.
Companies Represented
A technical gathering representing global ADC innovators, specialist linker-payload suppliers, conjugation CDMOs, and fill-finish experts.
Networking Hours
Connect with technical leaders to solve supply chain fragmentation, harmonise analytical standards, and accelerate the commercialisation of next-gen ADCs.
